预防性夹闭在口服抗凝药患者中预防息肉切除后出血的有效性:倾向评分分析
本研究为2012至2020年倾向评分加权回顾性队列研究,纳入547例口服抗凝药并接受结肠镜息肉切除术患者共1485枚息肉。预防性夹闭与息肉切除后出血风险降低无关(OR 1.19;95%CI .73-1.95;P=.497);热切除法出血风险显著更高(OR 9.76;95%CI 3.94-32.60;P<.001);DOAC亚组中预防性夹闭与较低出血风险相关(OR .36;95%CI .16-.82;P=.015)。
要点
- 预防性夹闭未降低口服抗凝药患者整体息肉切除后出血风险(OR 1.19;95%CI .73-1.95;P=.497)。
- 热切除法较冷活检或圈套息肉切除术显著增加出血风险(OR 9.76;95%CI 3.94-32.60;P<.001)。
- DOAC亚组中预防性夹闭与较低出血风险相关(OR .36;95%CI .16-.82;P=.015)。
核心结论
- 预防性夹闭与口服抗凝药患者整体息肉切除后出血风险降低无关。
- 在抗凝患者中应最大化使用冷圈套息肉切除术。
研究设计与样本
- 2012至2020年倾向评分加权回顾性队列研究。
- 纳入547例口服抗凝药并接受结肠镜息肉切除术患者,共1485枚息肉。
- 采用倾向评分逆概率治疗加权模型比较预防性夹闭组与未夹闭组,并将不平衡变量纳入多变量分析的双重稳健模型。
主要发现
- 预防性夹闭与息肉切除后出血风险降低无关(OR 1.19;95%CI .73-1.95;P=.497)。
- 热切除法较冷活检或圈套息肉切除术与显著更高的息肉切除后出血风险相关(OR 9.76;95%CI 3.94-32.60;P<.001)。
- DOAC亚组中预防性夹闭与较低的息肉切除后出血风险相关(OR .36;95%CI .16-.82;P=.015)。
关键数值与推荐
- 主要结局为临床显著延迟性息肉切除后出血,定义为30天内血红蛋白下降≥2 g/dL、输血或重复结肠镜止血的复合终点。
- 预防性夹闭与息肉切除后出血风险无关(OR 1.19;95%CI .73-1.95;P=.497)。
- 热切除法较冷活检或圈套息肉切除术的息肉切除后出血风险(OR 9.76;95%CI 3.94-32.60;P<.001)。
- DOAC亚组中预防性夹闭与息肉切除后出血风险(OR .36;95%CI .16-.82;P=.015)。
临床怎么用
- 在抗凝患者中应最大化使用冷圈套息肉切除术。
- 原文未据此给出预防性夹闭的推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Evidence of prophylactic clipping is inconsistent except for proximal and large colonic lesions in the general population. Although warfarin and direct oral anticoagulants (DOACs) are significant risk factors of postpolypectomy bleeding (PPB), dedicated studies to examine the benefit of prophylactic clipping in these high-risk patients remain limited. METHODS: We performed a propensity score-weighted retrospective cohort study from 2012 to 2020. Patients who received an oral anticoagulant and underwent colonoscopic polypectomy were included. Data were collected on baseline demographics, medications (anticoagulant, antiplatelet, and heparin bridging), and endoscopies (polyp number, location, size, morphology, histopathology, resection method and prophylactic clipping). Propensity-score models with inverse probability of treatment weighting were developed between prophylactic clipping and no clipping groups. Unbalanced variables were included in a doubly robust model with multivariate analysis. The primary outcome was clinically significant delayed PPB, defined as a composite endpoint of hemoglobin drop ≥2 g/dL, blood transfusion, or repeat colonoscopy for hemostasis within 30 days. RESULTS: Five hundred forty-seven patients with 1485 polyps were included. Prophylactic clipping was not associated with a reduced risk of PPB (odds ratio [OR], 1.19; 95% confidence interval [CI], .73-1.95; P = .497). The hot resection method was associated with a significantly higher risk of PPB (OR, 9.76; 95% CI, 3.94-32.60; P < .001) compared with cold biopsy or snare polypectomy. In a subgroup analysis, prophylactic clipping was associated with a lower PPB risk in patients on DOACs (OR, .36; 95% CI, .16-.82; P = .015). CONCLUSIONS: Prophylactic clipping was not associated with an overall reduced risk of PPB in patients on oral anticoagulants. The use of cold snare polypectomy should be maximized in anticoagulated patients.
引用
- Lau LHS, Guo CLT, Lee JKK, et al. Effectiveness of prophylactic clipping in preventing postpolypectomy bleeding in oral anticoagulant users: a propensity-score analysis. Gastrointest Endosc. 2022. PMID: 35413329. doi:10.1016/j.gie.2022.04.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。